Kronos Bio, Inc. announced that its Chief Financial Officer, Yasir Al-Wakeel, BM BCh, will resign from his position to pursue a new professional opportunity as the chief executive officer of a private biotechnology company. The Company has initiated a search to identify a suitable replacement for Dr. Al-Wakeel, who will remain with Kronos Bio until September 15, 2023 to ensure business continuity.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.02 USD | +3.89% | -2.86% | -18.40% |
05-09 | Earnings Flash (KRON) KRONOS BIO Reports Q1 Revenue $2.52M | MT |
05-09 | Kronos Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.40% | 59M | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- KRON Stock
- News Kronos Bio, Inc.
- Kronos Bio Announces Resignation of Yasir Al-Wakeel as Chief Financial Officer, Effective from September 15, 2023